Precision Medicine

AI precision medicine accelerates the search for rare disease treatment

AI and precision medicine are both changing drug discovery and development as we know it. Precision medicine that is powered by AI stands to be transformative, especially for the treatment of rare diseases. Elsevier was recently part of a collaboration that sought to demonstrate how AI precision medicine could lead researchers to new treatments for …

AI precision medicine accelerates the search for rare disease treatment Read More »

Rune Labs Lands $22.8M to for Neurology Precision Medicine Platform

What You Should Know: – Today, Rune Labs, founded by the former head of Google neuroscience, announced a $22.8M Series A round for the development and delivery of precision medicine for neurodegenerative and psychiatric disorders and diseases like dementia, Alzheimer’s, and Parkinson’s, as well as neurological conditions resulting from COVID infections. The round was led …

Rune Labs Lands $22.8M to for Neurology Precision Medicine Platform Read More »

Foundation Medicine Integrates with Epic EMR for Genomic Insights for Precision Cancer Care

What You Should Know:  – Foundation Medicine (FMI) announced today a partnership to integrate its comprehensive genomic testing services into Epic’s electronic medical record (EMR) platform, making it easier for oncologists to order comprehensive genomic tests (CGP), review results, continually access clinical and genomic information and share among their care teams in order to develop …

Foundation Medicine Integrates with Epic EMR for Genomic Insights for Precision Cancer Care Read More »

AccessDX Acquires 2bPrecise from Allscripts for Actionable Precision Medicine Insights

What You Should Know: – AccessDX, a leading diagnostic laboratory, and diagnostic technology company has acquired 2bPrecise, a genomic and healthcare informatics innovator, from Allscripts Healthcare Solutions. This merger comes as advances in genetic research and medicine have driven skyrocketing demand for genetic testing, data, and insights by healthcare providers, laboratories, and consumers around the world. …

AccessDX Acquires 2bPrecise from Allscripts for Actionable Precision Medicine Insights Read More »

Sema4 goes public via SPAC merger

With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.

ViewPoints Interview: NephroSant’s Dr. Minnie Sarwal Shares Insights on QSant and the Need for Precision Medicine in Kidney Health

In an interview with PharmaShots, Dr. Minnie Sarwal, CEO and Co-Founder of NephroSant shares her view on the QSant and how this urine test can improve outcomes for transplant patients. She also shed light on the need for precision therapies in kidney transplant care. Shots: NephroSant’s Qsant is a needle-free urine test that helps in …

ViewPoints Interview: NephroSant’s Dr. Minnie Sarwal Shares Insights on QSant and the Need for Precision Medicine in Kidney Health Read More »

INVEST Precision Medicine Conference Video: Biologics and the Supply Chain Ballet

This panel highlights how different organizations in the biopharma supply chain are addressing the inherent challenges of producing and delivering cell and gene therapies and biologics.

INVEST Precision Medicine Conference Video: How Can We Improve Health Equity in Precision Medicine?

Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?

INVEST Precision Medicine Pitch Perfect Health IT and Life Science tracks (video)

Video from the Health IT and Life Science tracks of our Pitch Perfect contest at INVEST Precision Medicine is now available to view.  

Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends

The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.

How easy is it for patients to access cell and gene therapies in Europe?

Cell and gene therapies have the potential to produce dramatic improvements in quality of life and survival for severe and often rare diseases. Currently, however, the cost of these treatments is high and access is sometimes limited. To identify some of these challenges in Europe EURODIS conducted an evaluation of country-specific challenges with respect to …

How easy is it for patients to access cell and gene therapies in Europe? Read More »

Precision medicine is growing fast. Can hospitals and clinicians can keep pace?

New technologies that enable precision medicine approaches to treating disease are reaching more patients. But panelists speaking at MedCity News’ INVEST Precision Medicine Conference added that advances in technology are happening faster than the ability of hospitals and health systems to keep pace.

INVEST Precision Medicine conference kicks off today. Register now to be part of the conversation.

Register for the INVEST Precision Medicine conference, which kicks off today. Over the next three days industry experts will talk about precision medicine developments across pediatrics, bioinformatics, startups and more.

AI Disease Modeling Supports Precision Medicine for Cancer

Precision medicine has offered a lot of hope for the treatment of cancer, as it makes it possible to tackle the multi-faceted disease with a more personalized, patient-specific approach. Meanwhile, researchers are also becoming increasingly interested in applications for artificial intelligence in the development of drugs and therapies. Could AI and precision medicine work together …

AI Disease Modeling Supports Precision Medicine for Cancer Read More »

US Orthopedic Alliance Taps 2bPrecise to Power Precision Medicine Program

What You Should Know:  2bPrecise, a precision medicine company, announced that the US Orthopedic Alliance (USOA) is leveraging 2bPrecise’ pharmacogenomics (PGx) solution to help physicians identify potentially dangerous drug-gene interactions. – The 2bPrecise platform will deliver workflow, data management and clinical decision functionality to USOA providers ordering pharmacogenomic tests (PGx). Specifically, doctors can leverage test results to …

US Orthopedic Alliance Taps 2bPrecise to Power Precision Medicine Program Read More »

Health IT Advances Precision Medicine

Precision medicine creates treatment and prevention strategies that meet patient needs by considering individual variability in their genome, environment, and lifestyle. While precision medicine can revolutionize health care, it requires access to an unprecedented volume and variety of data, and an infrastructure that rapidly brings new discoveries to bear.  Recently, we published an article in the Journal of the American Medical …

Health IT Advances Precision Medicine Read More »

PHINs: Addressing the Fundamental Flaws that Have Broken Healthcare

 Brad Bostic, CEO, hc1 The fundamental problem with healthcare can be summed up in one sentence:  We expect healthcare services that cater to our individual needs, yet the health care system operates under a one-size-fits-all, trial-and-error model. It is a model that results in missed diagnoses, protracted illnesses, and even premature death and wastes $935 …

PHINs: Addressing the Fundamental Flaws that Have Broken Healthcare Read More »

A preview of the INVEST Precision Medicine conference June 9-11

The conference highlights the intersections of technology and life sciences through the prism of precision medicine. The topics at the conference span pediatric innovation in precision medicine, how tech companies are addressing clinical trial challenges, supply chain management, and more.

Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching

What You Should Know: – Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, …

Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching Read More »

Novartis expands in radio-oncology again with $1.3bn Artios alliance

In its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus alliance with UK biotech Artios Pharma to develop precision medicines for cancer. The collaboration will focus on combining Artios’ DNA damage response (DDR) drug candidates with Novartis’ radioligand therapies, which consist of tumour-targeting molecules carrying radioactive isotopes …

Novartis expands in radio-oncology again with $1.3bn Artios alliance Read More »

COSMIC database matches drugs to cancer mutations

The world’s largest database of cancer mutations can now be used to link mutations with drug treatments in what promises to be a step forward in precision oncology.  The COSMIC (Catalogue of Somatic Mutations in Cancer) database, operated by the Wellcome Sanger Institute, grew out of the work of the Cancer Genome Project and has …

COSMIC database matches drugs to cancer mutations Read More »

Amgen’s $1.9B Five Prime deal adds to cancer drug pipeline and Asia strategy

The acquisition brings Amgen a novel Phase 3-ready drug for gastric cancers. For Five Prime Therapeutics, the deal is a lifeline following a series of clinical and financial setbacks that left much of the biotech’s fortunes resting on its lead antibody drug.

How digital health impacts the development and adoption of cancer immunotherapies [Sponsored]

In an interview, BrightInsight Co-founder and CEO Kal Patel, MD, offered a preview of the report, The Role of Digital Health in Immuno-oncology Therapy Development and Adoption.

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network

What You Should Know: – Syapse raises 68M in equity investment  led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence  through Syapse’s Learning Health Network. – The Syapse Learning Health Network is a global precision oncology data sharing network, improving cancer care across communities by using real-world data to …

Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network Read More »

Does pharmacogenomics obviate the need for race-based treatment and screening?

Let’s say that drug A works better for one race than another. Or that disease prevalence is more common for some races than others. Despite the goal to be color-blind in medicine, racial information can prove useful. For instance, sickle cell disease is much more common among African Americans in the US than other races. …

Does pharmacogenomics obviate the need for race-based treatment and screening? Read More »

Standards Beyond the Clinic: Capturing Patient Health Data to Advance Precision Medicine

Does the neighborhood I live in affect my health? How am I going to be able to see the specialist without a car? Can I share blood pressure and blood sugar readings I take at home with my doctor so she can monitor how I’m doing? These critical questions have helped to drive precision medicine …

Standards Beyond the Clinic: Capturing Patient Health Data to Advance Precision Medicine Read More »

Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease

What You Should Know: – Frenova Renal Research, a global division of Fresenius Medical Care, announced today that it has started to enroll patients in its new endeavor to build the world’s largest genomics registry targeting kidney disease. – The registry will be used to help advance understanding of the genetic drivers of kidney disease and …

Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease Read More »

Armed with $270M in capital, Scorpion Therapeutics aims to broaden the reach of precision oncology

Founded in 2020, Scorpion is agnostic about the potential therapies and targets it will explore with what it describes as its drug-hunting engine. But the company is hoping to unveil its first drug candidate this year.

Meaningful Use of Genomics Requires Informatics Beyond EMRs

Assaf Halevy, Founder and CEO of 2bPrecise Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care.  But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic …

Meaningful Use of Genomics Requires Informatics Beyond EMRs Read More »

Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders

Donovan Quill, President and CEO, Optime Care Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. …

Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders Read More »

VHA Innovation Ecosystem Taps MDClone to Leverage Synthetic Data for Faster Healthcare to Veterans

What You Should Know: – Data analytics and digital health company MDClone announced a partnership with the Department of Veterans Affairs’ (VA) VHA Innovation Ecosystem to democratize data and provide better, smarter, faster healthcare to U.S Veterans. – By leveraging MDClone’s data platform, the VHA is able to tackle this massive problem by securely accessing, …

VHA Innovation Ecosystem Taps MDClone to Leverage Synthetic Data for Faster Healthcare to Veterans Read More »

Getting the right data to doctors is next hurdle for precision medicine

The future of precision medicine will come only as quickly as doctors can pick out clinically useful information from the genetic data being gathered on their patients.

3D Printing Makes Medical Devices More Personal

Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made it possible to create treatments for disease that are more suited to the individual. But personalized medicine isn’t a concept that only applies to drug therapies. It is also highly …

3D Printing Makes Medical Devices More Personal Read More »

3D Printing Makes Medical Devices More Personal

Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made it possible to create treatments for disease that are more suited to the individual. But personalized medicine isn’t a concept that only applies to drug therapies. It is also highly …

3D Printing Makes Medical Devices More Personal Read More »

Amazon Launches HealthLake for Healthcare Orgs to Aggregate & Structure Health Data

What You Should Know: – Amazon today announced the launch of Amazon HealthLake, a new HIPAA-eligible service enables healthcare organizations to store, tag, index, standardize, query, and apply machine learning to analyze data at petabyte scale in the cloud. – Cerner, Ciox Health, Konica Minolta Precision Medicine, and Orion Health among customers using Amazon HealthLake. …

Amazon Launches HealthLake for Healthcare Orgs to Aggregate & Structure Health Data Read More »

5 Myth-Busting New Hospital ADT Notification Requirements

 Claudia Williams, CEO of Manifest MedEx When doctors know their patients have been to the hospital, they can act fast to provide needed support. Widespread use of hospital event notifications is associated with all kinds of health benefits, including a 10 percent decrease in readmissions for Medicare beneficiaries. These event notifications are one of the …

5 Myth-Busting New Hospital ADT Notification Requirements Read More »

Mark your calendars for our virtual INVEST Precision Medicine conference, December 9-11

Here’s a preview of some of the panel discussions at INVEST Precision Medicine, including diagnostics, investment trends, and building a bioinnovation hub.

To Solve Healthcare Interoperability, We Must ‘Solve the Surround’

Peter S. Tippett, MD, Ph.D., Founder & CEO of careMesh Interoperability in healthcare is a national disgrace. After more than three decades of effort, billions of dollars in incentives and investments, State and Federal regulations, and tens of thousands of articles and studies on making all of this work — we are only slightly better …

To Solve Healthcare Interoperability, We Must ‘Solve the Surround’ Read More »

KēlaHealth Lands $12.9M to Expand AI-Powered Surgical Intelligence Platform

What You Should Know: –  KēlaHealth announced their Series A round (combined seed and Series A) of $12.9M led by Sante Ventures and new innovation VC, Intuitive Ventures. – KēlaHealth, is a surgical intelligence engine that applies a dynamic cycle of patient-specific predictions, stratified interventions, and outcomes tracking to reduce surgical complications – KēlaHealth is …

KēlaHealth Lands $12.9M to Expand AI-Powered Surgical Intelligence Platform Read More »

Holy Name, Sheba Medical Center Partner to Develop Digital Health Solutions

Sheba ARC Innovation Center What You Should Know: – Holy Name Medical Center based in New Jersey and Israel’s Sheba Medical Center, the largest medical center in the Middle East announced a strategic partnership to develop digital health and telehealth solutions, The Times of Israel reports. – As part of the partnership, Holy Name’s team …

Holy Name, Sheba Medical Center Partner to Develop Digital Health Solutions Read More »

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

What You Should Know: – Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression. – In work funded through the PHDA-AWS collaboration, a research team led by Shandong Wu, an associate professor at the University of Pittsburgh …

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models Read More »

Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval

The company announced Wednesday the FDA approval of its liquid biopsy test, the second to win an agency nod in less than a month, saying it would launch the product on Friday. The FDA acquired the first ever liquid biopsy companion diagnostic, Guardant Health’s Guardant360 CDx, on Aug. 10.

AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases

Shots: The two companies will develop and launch precision medicine strategies for CV, renal, and metabolic diseases. The first stage in the collaboration will use KidneyIntelX to improve outcomes for patients with CKD and its complications, in coordination with the Mount Sinai Health System The first stage will assess the impact of AI-enabled in vitro …

AstraZeneca Collaborates with RenalytixAI to Develop Precision Medicine for Chronic Diseases Read More »

The age of precision in the post COVID-19 world

Health and care have been inexorably moving towards a new paradigm – one where the nature of the interactions are more personalised and require the person to be more active in their pursuit of reducing risks that have an adverse effect upon the development of non-communicable diseases, says Dr Charles Alessi, chief clinical officer at …

The age of precision in the post COVID-19 world Read More »

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

What You Should Know: The FDA and Syapse announce research collaboration expansion to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19. As part of the research, Syapse is partnering with FDA’s Oncology Center of Excellence to investigate methods to derive RWD from multiple sources including electronic health records, registries …

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer Read More »

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical

What You Should Know: – Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. – Deal expected to close in 1H 2021. – Varian Medical will maintain its brand name and operate “independently” – Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as …

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical Read More »

Most hospital, health systems see increase in genomics, genetics vendors by 2023, report finds

The new report, from the University of Pittsburgh Medical Center’s Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondents said they were providing genomic or genetic testing or planning to.

HHS Taps Fenway Health as Pilot Site for Precision Medicine Project

What You Should Know: – Fenway Health has been selected as the pilot site to participate in the Advancing Standards for Precision Medicine (ASPM) project. – The ASPM project is focused on how healthcare providers can systematically identify the socio-economic factors that may impact the health of patients in order to provide more individualized care …

HHS Taps Fenway Health as Pilot Site for Precision Medicine Project Read More »

Empowering Patients to Advance Precision Medicine, One EHR at a Time

Electronic health record (EHR) systems store incredibly rich data about individual patients, but historically, individuals have been unable to access this information easily and share it for research. However, use of patients’ data could accelerate scientific discovery and progress toward precision medicine. Permitting patients to connect and share their data with researchers—while maintaining the security …

Empowering Patients to Advance Precision Medicine, One EHR at a Time Read More »

Clinical Genomics Data for Precision Medicine

Genomic data—information about the complete set of genes that make up each individual—have the potential to revolutionize healthcare and usher in a new era of precision medicine and scientific discovery. However, there is currently no standard way of presenting genomic data, and the standards for integrating those data with electronic health record (EHR) and other …

Clinical Genomics Data for Precision Medicine Read More »